RFCA
PETX

R&F Capital Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History

R&F Capital Advisors’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$56K Buy
+10,506
New +$70.9K 0.01% 643

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

R&F Capital Advisors's PETX Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Aratana Therapeutics, Inc. (PETX) in Q1 2017: 10,506 shares worth $56K. The stake represents 0.01% of the portfolio and ranks #643 among its holdings.

98 funds tracked by Wall St. Rank hold PETX as of Q1 2017.

  • R&F Capital Advisors held 10,506 shares of Aratana Therapeutics, Inc. worth $56K as of Q1 2017.
  • Aratana Therapeutics, Inc. was a new R&F Capital Advisors position in Q1 2017.
  • Aratana Therapeutics, Inc. made up 0.01% of R&F Capital Advisors's portfolio in Q1 2017, its #643 holding.
  • 98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.